إعلان
إعلان

APLT

APLT logo

Applied Therapeutics, Inc. Common Stock

0.10
USD
برعاية
0.00
+0.80%
٠٩ يناير, ١٥:٥٧ UTC -5
مغلق
exchange

بعد الإغلاق

0.10

0.00
0.00%

تقارير أرباح APLT

النسبة الإيجابية المفاجئة

APLT تفوق 15 من 27 آخر التقديرات.

56%

التقرير التالي

بيانات التقرير القادم
١٣ أبريل ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.11
التغير الضمني من Q3 25 (Revenue/ EPS)
-100.00%
/
-15.38%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-133.33%

Applied Therapeutics, Inc. Common Stock earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, APLT reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 8.96% surprise. Revenue reached 1.00 مليون, compared to an expected 340.00 ألف, with a 194.12% difference. The market reacted with a -70.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an نقصان of -15.38% EPS, and نقصان of -100.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Applied Therapeutics, Inc. Common Stock reported EPS of -$0.13, beating estimates by 8.96%, and revenue of $1.00M, 194.12% above expectations.
The stock price moved down -70.33%, changed from $0.91 before the earnings release to $0.27 the day after.
The next earning report is scheduled for ١٣ أبريل ٢٠٢٦.
Based on 6 المحللين, Applied Therapeutics, Inc. Common Stock is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان